She combines her scientific background with strong experience in gene therapyand oncology with key focus on the price and reimbursement processes in EU, Canada and Israel healthcare
systems including solid hands-on experience in market access in Italy and Greece. Her expertise ranges from market access strategy,
evidence generation and value demonstration, health economics, price, policies and reimbursement of advanced therapy medicinal products.
Together with her expertise she brings a positive attitude to collaborations thanksto excellent networking, listening and presentation skills.